Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: GUILD ASSOCIATES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-30 to 2026-09-29
Current total value of award: $306718
Description: SBIR PHASE I (NIMH TOPIC 3): POINT-OF-CARE AND PHARMACY-BASED ANTIRETROVIRAL DRUG ADHERENCE ASSAYS - POINT-OF-CARE ANTI-RETROVIRAL DRUG ADHERENCE IMPEDANCE SPECTROSCOPY DEVICE